REQUEST A DEMO
Total
USD $0.00
Search more companies

Supramedex S.R.O. (Czech Republic)

Main Activities: Wholesale Trade | Other Miscellaneous Nondurable Goods Merchant Wholesalers
Full name: Supramedex S.R.O. Profile Updated: August 24, 2026
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English Download a sample report

Supramedex S.R.O. is a company based in Czech Republic, with its head office in Prague. The company operates in the Wholesale Trade industry. Supramedex S.R.O. was incorporated on October 27, 2022. 1 - 5 (2024) employees currently work for Supramedex S.R.O.. There was a net sales revenue increase of 3.76% reported in Supramedex S.R.O.’s latest financial highlights for 2025. Over the same period, its total assets grew by 50.64%. The net profit margin of Supramedex S.R.O. increased by 1.7% in 2025.

Headquarters
Stepanska 1742/27
Prague; The City of Prague; Postal Code: 11000

Contact Details: Purchase the Supramedex S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Supramedex S.R.O. report to view the information.
Registered Capital:
Purchase the Supramedex S.R.O. report to view the information.
Financial Auditors:
Purchase the Supramedex S.R.O. report to view the information.
Incorporation Date:
October 27, 2022
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
50%
Company Performance
Financial values in the chart are available after Supramedex S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
3.76%
Total Operating Revenue
3.2%
Operating Profit
19.22%
EBITDA
22.35%
Net Profit/Loss for the Period
15.38%
Total Assets
50.64%
Total Equity
93.84%
Operating Profit Margin
3.03%
Net Profit Margin
1.7%
Return on Equity (ROE)
-32.92%
Quick Ratio
3.6%
Cash Ratio
0.49%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?